129 related articles for article (PubMed ID: 27125206)
1. Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing.
Pardanani A; Lasho T; Wassie E; Finke C; Zblewski D; Hanson CA; Ketterling RP; Gangat N; Tefferi A
Leukemia; 2016 Sep; 30(9):1924-6. PubMed ID: 27125206
[No Abstract] [Full Text] [Related]
2. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing.
Lee JS; Seo H; Im K; Park SN; Kim SM; Lee EK; Kim JA; Lee JH; Kwon S; Kim M; Koh I; Hwang S; Park HW; Kang HR; Park KS; Kim JH; Lee DS
PLoS One; 2017; 12(10):e0185602. PubMed ID: 29088303
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome.
Andersen CL; Nielsen HM; Kristensen LS; Søgaard A; Vikeså J; Jønson L; Nielsen FC; Hasselbalch H; Bjerrum OW; Punj V; Grønbæk K
Oncotarget; 2015 Dec; 6(38):40588-97. PubMed ID: 26497854
[TBL] [Abstract][Full Text] [Related]
5. Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.
Leiva O; Baker O; Jenkins A; Brunner AM; Al-Samkari H; Leaf RK; Rosovsky RP; Fathi AT; Weitzman J; Bornikova L; Nardi V; Hobbs GS
JAMA Netw Open; 2021 Aug; 4(8):e2119812. PubMed ID: 34357393
[TBL] [Abstract][Full Text] [Related]
6. Chronic eosinophilic leukemia-not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformation.
Helbig G; Soja A; Bartkowska-Chrobok A; Kyrcz-Krzemień S
Am J Hematol; 2012 Jun; 87(6):643-5. PubMed ID: 22473587
[TBL] [Abstract][Full Text] [Related]
7. Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature.
Podjasek JC; Butterfield JH
Leuk Res; 2013 Apr; 37(4):392-5. PubMed ID: 23332454
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes.
Helbig G; Hus M; Brzeźniakiewicz-Janus K; Woszczyk D; Lewandowski K; Kyrcz-Krzemień S
Pol Arch Med Wewn; 2015; 125(9):692-4. PubMed ID: 26200714
[No Abstract] [Full Text] [Related]
9. [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital].
Kim DW; Shin MG; Yun HK; Kim SH; Shin JH; Suh SP; Ryang DW
Korean J Lab Med; 2009 Jun; 29(3):185-93. PubMed ID: 19571614
[TBL] [Abstract][Full Text] [Related]
10. Persistent hypereosinophilia with Wells syndrome.
Powell J; Salim A; Muc R; Colloby P; Kaur MR
Clin Exp Dermatol; 2013 Jan; 38(1):40-3. PubMed ID: 22607377
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.
Roche-Lestienne C; Lepers S; Soenen-Cornu V; Kahn JE; Laï JL; Hachulla E; Drupt F; Demarty AL; Roumier AS; Gardembas M; Dib M; Philippe N; Cambier N; Barete S; Libersa C; Bletry O; Hatron PY; Quesnel B; Rose C; Maloum K; Blanchet O; Fenaux P; Prin L; Preudhomme C
Leukemia; 2005 May; 19(5):792-8. PubMed ID: 15772698
[TBL] [Abstract][Full Text] [Related]
12. [A case of ischemic colitis induced by hypereosinophilic syndrome].
Ichikawa Y; Takeuchi M; Yamada M; Hosoi T; Mabuchi T; Okada A; Tomida H; Suhara H; Koya T; Suzuki H; Okada Y
Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2074-81. PubMed ID: 23221056
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation.
Schwaab J; Jawhar M; Naumann N; Schmitt-Graeff A; Fabarius A; Horny HP; Cross NC; Hofmann WK; Reiter A; Metzgeroth G
Ann Hematol; 2016 Mar; 95(4):557-62. PubMed ID: 26797429
[TBL] [Abstract][Full Text] [Related]
14. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
Jin JJ; Butterfield JH; Weiler CR
J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
16. Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.
Helbig G; Majewski M; Wieczorkiewicz A; Bober G; Grzegorczyk J; Dziaczkowska-Suszek J; Soja A; Bartkowska-Chrobok A; Krawczyk M; Krzemień S
Leuk Res; 2009 Mar; 33(3):e1-2. PubMed ID: 18466967
[No Abstract] [Full Text] [Related]
17. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.
Roufosse F; Goldman M; Cogan E
Semin Respir Crit Care Med; 2006 Apr; 27(2):158-70. PubMed ID: 16612767
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic hypereosinophilic syndrome revealed by encephalopathy.
Wang L; Wei L; Wang JC; Liu YH; Deng YC
J Clin Neurosci; 2012 Dec; 19(12):1746-8. PubMed ID: 22999560
[TBL] [Abstract][Full Text] [Related]
19. [Hypereosinophilic dermatitis. An overlooked diagnosis?].
Kemmler N; Peitsch WK; Glorer E; Goerdt S
Hautarzt; 2005 Nov; 56(11):1060-7. PubMed ID: 16267687
[TBL] [Abstract][Full Text] [Related]
20. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Smith KJ; Jacobson E; Hamza S; Skelton H
Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
